Xenobiotica is a peer-reviewed medical journal that publishes comprehensive research papers on all areas of xenobiotics. It is published by Informa plc and covers six main areas:
Culture, Medicine and Psychiatry is a cross-cultural peer-reviewed medical journal published quarterly by Springer Science+Business Media.
Expert Opinion on Pharmacotherapy is a peer-reviewed medical journal publishing review articles and original papers on new pharmacotherapies. It is published by Informa and the editor-in-chief is Dimitri P. Mikhailidis.
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse. The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974. The journal is also indexed in MEDLINE.
Expert Opinion on Therapeutic Patents is a monthly peer-reviewed medical journal covering pharmaceutical patent information across all therapy areas. Each review includes an "expert opinion" section, in which authors provide their personal view on the current status and future direction of the research discussed. The journal was established as Current Opinion on Therapeutic Patents in 1991, and changed to the current name in 1994. It is published by Informa. The editor-in-chief is Claudiu T. Supuran.
Expert Opinion on Investigational Drugs is a monthly peer-reviewed medical journal covering developments in pharmaceutical research, from animal studies through to early clinical investigation. The journal's scope includes therapeutics in many areas: pulmonary-allergy, dermatology, gastrointestinal, arthritis, infectious disorders, endocrine and metabolic, central and peripheral nervous system, cardiovascular and renal, and oncology.
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001.
Molecular Pharmaceutics is a peer-reviewed scientific journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems, including physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science.
Expert Opinion on Drug Safety is an international peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre.
Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio.
Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University.
Drug Delivery is a peer-reviewed open access medical journal covering research on all aspects of drug delivery, a core aspect of drug development. It is published by Taylor & Francis and since 2009 the editor-in-chief is Vladimir Torchilin. Alfred Stracher was the founder and co-editor prior to his passing in 2013. According to the Journal Citation Reports, the journal has a 2018 impact factor of 3.095.
Journal of Drug Targeting is a peer-reviewed medical journal published by Informa that covers research on all aspects of drug delivery and drug targeting for molecular and macromolecular drugs. The editor in chief is Saghir Akhtar.
The Journal of Controlled Release is a biweekly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal covers research on the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included.
SLAS Technology is a peer-reviewed scientific journal published by the Society for Laboratory Automation and Screening in partnership with Elsevier. The editor-in-chief is Edward Kai-Hua Chow, Ph.D.. The journal explores ways in which scientists adapt advancements in technology for scientific exploration and experimentation, especially in life sciences research and development. This includes drug-delivery; diagnostics; biomedical and molecular imaging; personalized and precision medicine; high-throughput and other laboratory automation technologies; micro/nanotechnologies; analytical, separation and quantitative techniques; synthetic chemistry and biology; informatics ; and more. The journal was published from 1996 through 2016 with the title Journal of Laboratory Automation. Its name changed in 2017 to more accurately reflect the evolution of its editorial scope.[1]
Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram, and has since expanded to other academic fields. Frontiers is based in Lausanne, Switzerland, with other offices in London, Madrid, Seattle and Brussels. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.
Advanced Drug Delivery Reviews is a peer-reviewed medical journal covering research involving the controlled release and delivery of drugs and other biologically active agents.
Current Opinion in Food Science is a peer-reviewed scientific journal published by Elsevier. It covers the field of food Science and nutrition, and is divided into themed sections. The journal was established in 2015 as part of Elsevier's Current Opinion series, which is a collection of journals publishing invited reviews aimed at experts and non-specialists on various disciplines. The current editors-in-chief are A.G. Marangoni and A. Sant'Ana.
